MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-10-0027978
Nektap Pharmaceuticals Private Limited
Nektap Pharmaceuticals Private Limited - trading in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹2.49 Lakh
▼ 36% YoY
Net loss · FY 2024
₹6.39 Lakh
Net margin -256.2%
EBITDA · FY 2024
-₹6.39 Lakh
EBITDA margin -256.2%
Authorised capital
₹2 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Directors on board
4
As per MCA filings
Active GSTINs
1
GST registered
About Nektap Pharmaceuticals Private Limited
Data last updated:
Nektap Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 07 December 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2017PTC326911. Its GSTIN is 09AAFCN8635C1ZD (Uttar Pradesh).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Vishal Sahai and Aliya Rizvi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at L – 155 G.F Plot No. A – 63 Kh No. 17/6 Vijay Enclave Mahavir Encla, Ve, New Delhi, Delhi, India – 110075.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.49 Lakh, a decline of 36% compared to the previous year. For the same year it recorded a net loss of ₹6.39 Lakh (net margin -256.2%) and EBITDA of -₹6.39 Lakh (EBITDA margin -256.2%).
Nektap Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-10-0027978). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U51909DL2017PTC326911
Registration Number 326911
Incorporation Date 07 December 2017
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-10-0027978
Recognitions & Rankings of Nektap Pharmaceuticals
Contact details
Nektap Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressL – 155 G.F Plot No. A – 63 Kh No. 17/6 Vijay Enclave Mahavir Encla, Ve, New Delhi, Delhi, India – 110075
- IndustryTrading, Specialty, Wholesale
To see the full contact details of Nektap Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Nektap Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Nektap Pharmaceuticals is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Nektap Pharmaceuticals Private Limited, buy the company report.
Financials of Nektap Pharmaceuticals Private Limited
FY 2025 filings availableNektap Pharmaceuticals Private Limited reported revenue of ₹2.49 Lakh (down 36% YoY) for FY 2024.
Revenue · FY 2024
₹2.49 Lakh ▼ 36%
Net loss · FY 2024
₹6.39 Lakh margin -256.2%
EBITDA · FY 2024
-₹6.39 Lakh margin -256.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 36%
EBITDA CAGR growth
1 year
▼ 2%
5 years · compounded
▼ 154%
Revenue fell 36% in the latest year. EBITDA fell 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹6.39 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹6.39 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -256.2% | ||||
| Net Profit Margin | -256.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nektap Pharmaceuticals Private Limited, buy the company report.
Board of directors of Nektap Pharmaceuticals Private Limited
Nektap Pharmaceuticals has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vishal Sahai | Director | 07 Dec 2017 | 8 Years 10 Months | Current |
| Aliya Rizvi | Director | 23 Jul 2022 | 4 Years 3 Months | Current |
| Monika Saini | Director | 23 Jul 2022 | 4 Years 3 Months | Current |
| Sunil Shukla | Director | 01 Sep 2021 | 5 Years 1 Months | Current |
Legal cases
No court or tribunal cases involving Nektap Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nektap Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Nektap Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAFCN8635C1ZD | Uttar Pradesh | Active | 10 Jan 2022 |
To see the full GST registrations and return filing status of Nektap Pharmaceuticals Private Limited, buy the company report.
Recent activity
Nektap Pharmaceuticals Private Limited has 6 board changes on record since 2017: 4 appointments and 2 cessations. The latest: Aliya Rizvi was appointed as Director on 23 Jul 2022.
AGM
Nektap Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Nektap Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Appointed
Aliya Rizvi was appointed as Director.
Appointed
Monika Saini was appointed as Director.
Ceased
Sunil Shukla ceased to be Additional Director.
Ceased
Ashish Kumar Singh ceased to be Director.
Appointed
Sunil Shukla was appointed as Director.
Appointed
Vishal Sahai was appointed as Director.
Incorporation
07 Dec 2017
Nektap Pharmaceuticals Private Limited was registered on 07 Dec 2017 with Roc Delhi I & aged 8 years 10 months as per MCA records.
Frequently asked questions
Nektap Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in specialty, within the trading industry. It was incorporated on 07 December 2017 (9+ years old) and is registered under CIN U51909DL2017PTC326911.
Nektap Pharmaceuticals has 4 current directors:
- Vishal Sahai - Director
- Aliya Rizvi - Director
- Monika Saini - Director
- Sunil Shukla - Director
The latest financial statements of Nektap Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Nektap Pharmaceuticals is 09AAFCN8635C1ZD, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Nektap Pharmaceuticals is U51909DL2017PTC326911. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nektap Pharmaceuticals was incorporated on 07 December 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
Aliya Rizvi was appointed as Director on 23 Jul 2022. Monika Saini was appointed as Director on 23 Jul 2022. Sunil Shukla ceased to be Additional Director on 30 Nov 2021. Nektap Pharmaceuticals has 6 board changes on record in total.
Yes, Nektap Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-10-0027978).
The registered office of Nektap Pharmaceuticals is at L – 155 G.F Plot No. A – 63 Kh No. 176 Vijay Enclave Mahavir Encla, Ve, New Delhi, Delhi, India – 110075.
Nektap Pharmaceuticals operates in the trading industry, in the specialty segment.